Interestingly, DERL3 expression was found to be positively correlated with MZB1 expression in the clinical specimens from breast cancer patients, suggesting DERL3 may also participate tumor progression (Watanabe et al., 2020). This evidence concerns the gene MZB1 and neoplasm.